PRV-3279-2a Trial in Systemic Lupus

Clinical trial NCT05087628 · TERMINATED

Trial details

NCT number: NCT05087628
Sponsor: Provention Bio, a Sanofi Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2022-01-20
Primary completion: 2024-05-14
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.